Target intelligence / Profile preview

Rotavirus non-structural protein 4 (NSP4)

Target
NSP4
Molecular classification
Viral protein, Enterotoxin, Viroporin, Glycoprotein
01

Overview

Rotavirus non-structural protein 4 (NSP4) is a multifunctional transmembrane glycoprotein that serves as the first identified viral enterotoxin (Ball et al., 1996, Science). It is primarily localized to the endoplasmic reticulum (ER) of infected intestinal epithelial cells, where it acts as a viroporin to release calcium into the cytoplasm (Hyser et al., 2010, Journal of Virology). This elevation of intracellular calcium triggers a signaling cascade involving phospholipase C and the enteric nervous system, ultimately leading to the activation of calcium-activated chloride channels and the induction of secretory diarrhea (Morris et al., 1999, American Journal of Physiology). Additionally, NSP4 is vital for viral replication, serving as a receptor for the budding of double-layered particles into the ER lumen to acquire their outer capsid (Taylor et al., 1993, Journal of Virology). Given its dual role in viral assembly and pathogenesis, NSP4 is a significant target for therapeutic intervention, including the development of small-molecule inhibitors and neutralizing antibodies (Vanden Berghe et al., 2006, Journal of Virology).

Other names
Non-structural glycoprotein NSP4VP10Rotavirus enterotoxinNS28
02

Mechanism of action

NSP4 functions as a viral enterotoxin that induces a phospholipase C-dependent increase in cytosolic calcium, leading to the activation of calcium-activated chloride channels and subsequent secretory diarrhea.

03

Biological functions

Viral morphogenesisCalcium homeostasis regulationEnterotoxin activityChloride secretion inductionSignal transduction
04

Disease associations

Rotavirus infectionGastroenteritisDiarrhea
05

Safety considerations

Antigenic diversity across rotavirus genotypesPotential interference with host calcium-dependent signalingRisk of incomplete neutralization due to viral mutation
06

Interacting drugs

Nitazoxanide

2 more in the full profile.

07

Biomarkers

NSP4 stool antigenAnti-NSP4 serum IgAAnti-NSP4 serum IgG

Beyond the preview

Go deeper on Rotavirus non-structural protein 4 (NSP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rotavirus non-structural protein 4 (NSP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call